![Ranibizumab / Bevacizumab / Vascular endothelial growth factor / Genentech / Retinopathy of prematurity / Macular degeneration / MedWatch / Food and Drug Administration / Endophthalmitis / Medicine / Health / Pharmacology Ranibizumab / Bevacizumab / Vascular endothelial growth factor / Genentech / Retinopathy of prematurity / Macular degeneration / MedWatch / Food and Drug Administration / Endophthalmitis / Medicine / Health / Pharmacology](https://www.pdfsearch.io/img/666e3a175d4f1cd4323c9cf7a5cc515c.jpg)
| Document Date: 2014-03-31 07:24:10 Open Document File Size: 440,92 KBShare Result on Facebook
City South San Francisco / Rockville / / Company Development Chief Medical Officer Genentech Inc. / Genentech Inc. / HP / / Event Product Issues / / / IndustryTerm treatment of patients with metastatic colorectal cancer / / MedicalCondition proteinuria / dyspnea / exfoliative dermatitis / abdominal pain / epistaxis / congestive heart failure / hypertension / headache / retinal detachment / endophthalmitis / macular degeneration / nausea / stomatitis / metastatic colorectal cancer / upper respiratory infection / iatrogenic traumatic cataract / retinopathy of prematurity / nephrotic syndrome / vomiting / pain / periocular infections / diarrhea / constipation / rhegmatogenous retinal detachment / / MedicalTreatment chemotherapy / / Organization FDA / / Person Hal Barron / / / Position Vice President / / Product Intravitreal injections / AVASTIN / fluorouracil / LUCENTIS / growth / / ProvinceOrState Maryland / California / / Technology antibodies / chemotherapy / / URL www.accessdata.fda.gov/scripts/medwatch / /
SocialTag |